IP Library Granted Patent US 9,241,987
Granted Patent B2
US 9,241,987 · App. 13/510,863 · Granted Jan 26, 2016

Methods and compositions related to immunogenic fibrils

Inventors: Joel H. Collier (Western Springs, IL); Jai Simha Rudra (Galveston, TX)
Assignee: The University of Chicago
A61K39/385A61K2039/6031A61K2039/64Y10T428/2933
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,241,987
App. No.
13/510,863
Granted
Jan 26, 2016
Kind
B2
Abstract

Embodiments of the invention are directed to fibrillar adjuvants. Epitopes assembled into nanofibers by a short synthetic fibrillization domain elicited high antibody titers in the absence of any adjuvant.

Claims (9)

1. An immunogenic composition comprising a peptide fibril coupled to a plurality of antigens, wherein the peptide fibril comprises a plurality of self-assembling peptides, wherein the self-assembling peptide comprises an amino acid sequence of QQKFQFQFEQQ (SEQ ID NO: 1), and wherein an antigen is covalently coupled to a terminus of a self-assembling peptide.

2. The composition of claim 1 , wherein the peptide fibril has a length of at least 0.5 to 100 μm.

3. The composition of claim 1 , wherein the peptide fibril has a molecular weight of at least 10,000 da-7×10 8 da.

4. The composition of claim 1 , wherein an antigen is covalently coupled to the carboxy terminus of the self-assembling peptide.

5. The composition of claim 1 , wherein the antigens are peptides.

6. The composition of claim 5 , wherein the antigens are T cell and/or B cell epitopes.

7. The composition of claim 1 , wherein the antigens are polypeptides.

8. The composition of claim 7 , wherein the polypeptides are covalently coupled to the peptide fibril via a cutinase polypeptide.

9. A method of inducing an immune response to an antigen comprising administering the immunogenic composition of claim 1 in an amount sufficient to induce an immune response.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 22, 2012
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029164/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2012
From: RUDRA, JAI SIMHA; COLLIER, JOEL H.
To: THE UNIVERSITY OF CHICAGO
Reel/Frame 028574/0510 →
Continuity (2)
Provisional Application 61263213 · Nov 20, 2009
Related Publication 20120282292A1 · Nov 8, 2012